Lu177 PSMA Therapy is a treatment for patients with prostate cancer, especially those who have become refractory to conventional therapy. PSMA therapy targets and kills the cancer cells and improve the quality of life of patients by helping in pain control.
This is an FDA approved treatment form (approved by the name Pluvicto recently in USA), available in India since over ten years now. In our experience, it is a safe and effective treatment for metastatic prostate cancer. It costs much lesser in India as compared to Europe, USA or Australia.
The therapy administers targeted radiation to cancer cells, causing damage to these cells while sparing the normal tissue in the body. It is administered on day care basis and is well tolerated by most patients, with mild to minimal side effects.
The therapy must be administered by a nuclear medicine physician familiar with these treatments, after discussion with your treating oncologist and screening.
Please reach out to us for more information and discussing if you may benefit from this treatment.